IRWD
Ironwood Pharmaceuticals Inc
Price:  
4.30 
USD
Volume:  
855,334.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

IRWD WACC - Weighted Average Cost of Capital

The WACC of Ironwood Pharmaceuticals Inc (IRWD) is 6.2%.

The Cost of Equity of Ironwood Pharmaceuticals Inc (IRWD) is 8.60%.
The Cost of Debt of Ironwood Pharmaceuticals Inc (IRWD) is 4.40%.

Range Selected
Cost of equity 7.50% - 9.70% 8.60%
Tax rate 6.30% - 17.50% 11.90%
Cost of debt 4.00% - 4.80% 4.40%
WACC 5.6% - 6.8% 6.2%
WACC

IRWD WACC calculation

Category Low High
Long-term bond rate 3.9% 4.4%
Equity market risk premium 4.6% 5.6%
Adjusted beta 0.79 0.87
Additional risk adjustments 0.0% 0.5%
Cost of equity 7.50% 9.70%
Tax rate 6.30% 17.50%
Debt/Equity ratio 1.02 1.02
Cost of debt 4.00% 4.80%
After-tax WACC 5.6% 6.8%
Selected WACC 6.2%